Clinical Trial Results for Hyperparathyroidism (Pediatric)

2 Clinical Trials for Hyperparathyroidism (Pediatric)

Focus your search

      RECRUITING
      A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)
      Description

      The main objective of this study is to evaluate the safety, efficacy and pharmacokinetics of paricalcitol oral solution in pediatric participants of ages 0 to 9 years with SHPT associated with stage 5 CKD receiving Peritoneal Dialysis (PD) or Hemodialysis (HD). The 24-week study is divided into two 12-week dosing periods (Dosing Period 1 followed by Dosing Period 2).

      Conditions
      Chronic Kidney Disease (CKD)Secondary Hyperparathyroidism (SHPT)
      Talk to us
      RECRUITING
      A Study of Etelcalcetide in Pediatric Subjects With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
      Description

      This is a Phase 3 Study of Etelcalcetide in Pediatric Subjects With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis

      Conditions
      Secondary HyperparathyroidismChronic Kidney Disease
      Talk to us